Effects of Polymeric Mucin Expression on Lung Carcinogenesis

聚合粘蛋白表达对肺癌发生的影响

• 批准号: 10369926
• 负责人: Christopher M Evans
• 金额: --
• 依托单位: VA EASTERN COLORADO HEALTH CARE SYSTEM
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-07-01 至 2026-06-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10369926
• 关键词: 3-Dimensional; Address; Adenocarcinoma Cell; Affect; Age; Amino Acids; Anabolism; Animals; Apoptosis; Apoptotic; Binding; Biological Assay; Biology; Cancer Biology; Cancer Etiology; Carcinoma; Cell Line; Cell Nucleus; Cell Proliferation; Cells; Cellular biology; Chemoresistance; Chronic Disease; Data; Development; Dimerization; Disease; Distal; Endoplasmic Reticulum; Enzymes; Epithelial; Epithelial Cells; Family; Functional disorder; Gene Expression; Gene Proteins; Genes; Goals; Goblet Cells; Growth; Health; Host Defense; Human; Imaging Techniques; In Vitro; Individual; Inositol; Intervention; KRAS2 gene; KRASG12D; Knockout Mice; Link; Lung; Lung Adenocarcinoma; MUC5AC gene; MUC5B gene; Malignant Neoplasms; Malignant neoplasm of lung; Mammals; Measures; Mediating; Metabolism; Molecular; Mucinous; Mucins; Mucous Membrane; Mucous body substance; Mus; Mutation; Oncogenic; Pathogenesis; Patients; Pharmacology; Polymers; Populations at Risk; Positioning Attribute; Protein Isoforms; Recurrence; Research; Sampling; Severities; Signal Pathway; Signal Transduction; Signaling Protein; Survival Rate; System; Testing; Tissue imaging; Tobacco smoke; Transgenic Mice; Transgenic Model; Translations; Tumor Burden; Tumor Promotion; Urethane; Vascularization; Veterans; Xenograft procedure; animal imaging; cancer cell; cell growth; coping; demographics; disulfide bond; effective therapy; endoplasmic reticulum stress; experience; glycosylation; human tissue; improved; in vivo; inhibitor; innovation; lung carcinogenesis; molecular imaging; mortality; mortality risk; mouse model; neoplastic cell; novel; overexpression; proteostasis; sensor; service member; sugar; tool; treatment strategy; tumor; tumorigenesis

Lung cancer is the leading cause of cancer-related deaths, and risks are disproportionately high in veterans. Lung adenocarcinoma (LUAD) accounts for half of all lung cancer cases, but effective treatments are lacking in part due to an incomplete understanding of LUAD biology. LUAD tumors originate from airway secretory epithelia, and mucin expression is prevalent and associated with LUAD aggressiveness. However, mechanisms by which mucins affect LUAD pathogenesis are poorly understood. The overarching concept of this proposal is that aberrant epithelial growth in LUAD is potentiated by two polymeric mucins--MUC5AC and MUC5B. Though required for airway defense in health, MUC5AC and MUC5B misexpression in LUAD correlates with invasiveness, recurrence, and mortality, especially in patients with activating mutations in KRAS--the most common oncogenic driver of LUAD. We validated MUC5AC causatively in urethane and activated-Kras expression mouse models of LUAD. In animals lacking Muc5ac (‘MUC in humans, ‘Muc’ in mice), tumor number and size decreased by ~50%. The relative tumor-promoting effects of Muc5b on its own or with Muc5ac are not yet known. We seek to close this significance gap here. We also seek to determine molecular mechanisms for polymeric mucin-mediated tumor promotion. Studies by us and by others have identified numerous signals that stimulate LUAD, including mucinous LUAD subtypes. Upstream signaling pathways converge on mucins and their biosynthetic machinery. Individual MUC5AC and MUC5B molecules are extraordinarily large. They multimerize, and they become even more massive through addition of sugars to their central glycosylation domains. Accordingly, protein homeostasis (proteostasis) is tightly regulated during polymeric mucin biosynthesis. Mucin translation, folding, and dimerization occur in the endoplasmic reticulum (ER) and involve formation of hundreds of disulfide bonds. To handle these demands, mammals express a mucous cell specific isoform of the ER stress sensor inositol-requiring enzyme-1 (IRE-1, also called ER-to- nucleus signaling protein, or ERN). ERN1 is ubiquitously expressed and is crucial for ER stress-triggered apoptosis, but an isoform called ERN2 is restricted to mucous cells where it is required for sustaining mucin synthesis despite high levels of ER stress. This adaptation is accomplished by direct binding of ERN2 to ERN1 and subsequent suppression of ERN1-mediated pro-apoptotic signaling. While beneficial for host defense in health, apoptosis suppression could be detrimental in LUAD. We hypothesize that MUC5AC and MUC5B promote epithelial cell growth in LUAD via ERN2-dependent suppression of ER stress-induced apoptosis. The following three Specific Aims are proposed: 1) Test the hypothesis that MUC5AC/Muc5ac and MUC5B/Muc5b promote LUAD and mucinous LUAD; 2) Test the hypothesis that polymeric mucin expression in tumor cells promotes LUAD via ERN2/Ern2 dependent proteostasis dysfunction; 3) Test the hypothesis that polymeric mucin expression promotes ERN2/Ern2-dependent epithelial growth. Studies will utilize novel mouse models, cell lines, and patient samples to focus on significant causative links between mucins, ER stress, and LUAD. Innovative gene-editing tools will be used along with pharmacologic agents as interventions, and state of the art animal, tissue, and molecular imaging techniques will be applied. Completion of these aims has the potential to significantly impact the lives of veterans and their families. Our team comprises experts in mucin and cancer cell biology who are uniquely positioned to address questions that will improve our understanding of KRAS-induced LUAD. Findings could identify MUC5AC, MUC5B, and ERN2 as targets to directly limit LUAD growth and to improve strategies for this common but poorly treatable form of lung cancer.

肺癌是癌症相关死亡的主要原因，退伍军人患肺癌的风险高得不成比例。